ZipChip Metabolites Diluent

Hazard statements (CLP)

H226, H301, H301+H311+H331, H311, H331, H370

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

Hazard statements

see section 16 : H226 - Flammable liquid and vapour. H301+H311+H331 - Toxic if swallowed, in contact with skin or if inhaled. H370 - Causes damage to organs (optic nerve, central nervous system).

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling

Hazard pictograms

GHS02 GHS06 GHS08

Signal word

Danger

Contains

Methanol

Precautionary statements

P210 - Keep away from heat/sparks/open flames/hot surfaces. – No smoking. P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P308+P311 - IF exposed or concerned: Call a POISON CENTER or doctor. P403+P235 - Store in a well-ventilated place. Keep cool. Unknown acute toxicity (CLP) - SDS : 1% of the mixture consists of ingredient(s) of unknown acute toxicity (Oral) 1% of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal) 1% of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Vapours)) Unknown hazards to the aquatic environment (CLP) : Contains 1 % of components with unknown hazards to the aquatic environment

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %